RITA COLLINS: Open Payments
NPI 1144249475 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 46 payments from 9 companies in 2025. Trend: 2023 $1,120 · 2024 $1,247 · 2025 $896
Food & beverage: $887Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $197 |
| UCB, Inc. | 6 | $187 |
| Novartis Pharmaceuticals Corporation | 8 | $156 |
| Lilly USA, LLC | 5 | $108 |
| Organon LLC | 6 | $105 |
| PFIZER INC. | 3 | $59 |
| Galderma Laboratories, L.P. | 2 | $41 |
| GENZYME CORPORATION | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Bimzelx, SKYRIZI, TALTZ, RINVOQ, CIBINQO, VTAMA, NEMLUVIO, Rhapsido.
Industry payments across TX — which companies pay providers there.
